BioCentury
ARTICLE | Company News

Takeda, Abbott receive European approval

May 29, 2001 7:00 AM UTC

Takeda (Osaka, Japan) received marketing authorization from the European Commission for Ixense apomorphine sublingual tablet to treat erectile dysfunction (ED). The MAA was submitted in November 1999....